2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
2005 | | MR findings in eosinophilic infiltration of the liver. | 김영배, 김재근, 선주성, 원제환, 이기명, 정재연 |
2013 | | Novel method of stent insertion for malignant lower rectal obstruction with proximal releasing delivery system (with video). | 김재근, 김진홍, 신성재, 유병무, 이기명, 임선교, 정재연, 황재철 |
2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
2010 | | Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | 김재근, 정재연, 조성원 |
2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
2012 | | Revision and update on clinical practice guideline for liver cirrhosis | 김재근, 정재연, 조성원 |
2005 | | Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
2010 | | Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI. | 김선용, 김재근, 김태희, 박태준, 정재연 |